| 1 |
35218445 | Resistance to obinutuzumab-induced antibody-dependent cellular cytotoxicity caused by abnormal Fas signaling is overcome by combination therapies. | 2022 Feb 26 |
1 |
| 2 |
22249209 | Association of CD20 levels with clinicopathological parameters and its prognostic significance for patients with DLBCL. | 2012 Jul |
1 |
| 3 |
21842694 | [A case of Sjogren syndrome coexistent with MALT lymphoma occurring along the parotid gland and trachea]. | 2011 Jul |
1 |
| 4 |
19833600 | Monotherapy with anti-CD20 monoclonal antibody in a heart transplant recipient with sick sinus syndrome and posttransplantation lymphoproliferative disorder: a case report. | 2009 Oct |
1 |
| 5 |
18780832 | CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy. | 2008 Nov 15 |
1 |
| 6 |
10444162 | Cost-minimization analysis of CHOP, fludarabine and rituximab for the treatment of relapsed indolent B-cell non-Hodgkin's lymphoma in the U.K. | 1999 Jul |
1 |